Back to search

Article

MAPK pathway inhibitors enhance radioiodine sensitivity in anaplastic thyroid carcinoma through promoting NIS expression and ARF4-mediated NIS membrane transport

2026-02-18

Abstract excerpt

<title>Abstract</title> <p> <bold>Objective:</bold> Anaplastic thyroid cancer (ATC) patient develops resistance to radioactive iodine (RAI) due to diminished sodium-iodide symporter (NIS) expression and mislocalization to the cell membrane. MAPK pathway inhibitors have demonstrated efficacy in enhancing RAI avidity in radioiodine-refractory papillary thyroid carcinoma and ATC. Elucidating this mechanism may lea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
813fa22e-4a28-589f-9499-c6bb51e21217
DOI
10.21203/rs.3.rs-8501287/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MAPK pathway inhibitors enhance radioiodine sensitivity in anaplastic thyroid carcinoma through promoting NIS expression and ARF4-mediated NIS membrane transportDOI 10.21203/rs.3.rs-8501287/v1
Select a neighboring publication to make it the new centre.